See All Slides - tctmd.com

Slides

Presentation TCT 2012

Conclusions

Presenter: David Rizik

October 25, 2012

Presentation TCT 2012

“No Man's Land”: Managing Zone 0 and the Aortic Arch

Presenter: Wilson Szeto

October 25, 2012

Presentation TCT 2012

SEDUCE: A Prospective, Randomized Trial of Drug Coated Balloon vs. Everolimus-Eluting Stent in for BMS Restenosis: Optical Coherence Tomography Assessment

Presenter: Tom Adriaenssens

October 25, 2012

Presentation TCT 2012

Concominant Carotid and Coronary Disease

Presenter: Christos Christou

October 25, 2012

Presentation TCT 2012

Future DCB Technologies: Challenges and Opportunities

Presenter: Juan Granada

October 25, 2012

Presentation TCT 2012

Development of a Drug-Coated Scoring Balloon: Preliminary Results from the PATENT-C First-in-Human Study

Presenter: Gary Gershony

October 25, 2012

Presentation TCT 2012

Debate: Prasugrel or Ticagrelor Should be Used in Nearly All Cases!

Presenter: Dominick Angiolillo

October 25, 2012

Presentation TCT 2012

For: Treating Bystander Disease in the Primary PCI Setting Increases Risk!

Presenter: Ran Kornowski

October 25, 2012

$Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!$

Presentation TCT 2012

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Gilles Montalescot

October 25, 2012

Presentation TCT 2012

Case 4: Thoracic Aortic Dissection During Aortic Valve Implantation

Presenter: Ajay Sinhal

October 25, 2012

Advertisement

Slides

Conclusions

“No Man's Land”: Managing Zone 0 and the Aortic Arch

SEDUCE: A Prospective, Randomized Trial of Drug Coated Balloon vs. Everolimus-Eluting Stent in for BMS Restenosis: Optical Coherence Tomography Assessment

Concominant Carotid and Coronary Disease

Future DCB Technologies: Challenges and Opportunities

Development of a Drug-Coated Scoring Balloon: Preliminary Results from the PATENT-C First-in-Human Study

Debate: Prasugrel or Ticagrelor Should be Used in Nearly All Cases!

For: Treating Bystander Disease in the Primary PCI Setting Increases Risk!

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Case 4: Thoracic Aortic Dissection During Aortic Valve Implantation

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content